Single-Cell transcriptomics unveils metabolic and cellular dysregulation in striae gravidarum
Clicks: 2
ID: 313409
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
0.3
/100
2 views
1 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #119 of 304 articles by views in the british journal of dermatology
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 304 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
BACKGROUND: Striae gravidarum (SG) is a common skin condition characterized by disrupted dermal extracellular matrix (ECM) homeostasis. Despite its high prevalence, the underlying cellular and molecular pathogenesis remains poorly understood, particularly regarding fibroblast heterogeneity and metabolic dysregulation. OBJECTIVES: This study aimed to delineate the cellular landscape and molecular mechanisms of SG at single-cell resolution, with a focus on fibroblast subpopulation dynamics, intercellular communication, and metabolic reprogramming. METHODS: We performed integrated single-cell RNA sequencing (scRNA-seq) and single-nucleus RNA sequencing (snRNA-seq) on dermal specimens from human SG lesions and matched normal skin. Functional validation was conducted using qPCR, histological staining (H&E, EVG, picrosirius red), immunofluorescence, and Mendelian randomization analysis. RESULTS: SG skin exhibited significant cellular reorganization, with fibroblasts showing the most profound transcriptional changes. Intercellular communication analysis identified a dysregulated sender-receiver axis between the inflammatory, metabolically active sC7 subset and the reparative sC5 subset. Pseudotime analysis indicated a blocked differentiation from sC7 to sC5. The sC7 subset underwent specific fatty acid metabolic reprogramming, marked by upregulation of key enzymes including ACSBG1. Triacsin C treatment in primary PDPN⁺ reticular fibroblasts suppressed ECM gene expression and attenuated pro-fibrotic markers; notably, it also downregulated representative sC7-associated genes while upregulating sC5-associated genes, suggesting partial restoration of a reparative transcriptional program. Furthermore, local Acsbg1 silencing in dorsal skin alleviated SG-like dermal remodeling in the mouse model, with improved dermal architecture, collagen organization, and elastic fiber integrity. CONCLUSIONS: Targeting ACSBG1-mediated fatty acid metabolic reprogramming in pro-fibrotic fibroblast subsets restores a reparative transcriptional programme and ameliorates dermal ECM disruption in SG. These findings identify ACSBG1 as a potential therapeutic target for SG.
| Reference Key |
openalex_W7161398398
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Yu Cheng, Chen Liang, Zixin Cai, Zhuoyuan Li, YiDan Sun, Xiujun Fu, Shuaijun Li, Caiyue Liu, C Wang |
| Journal | the british journal of dermatology |
| Year | 2026 |
| DOI |
10.1093/bjd/ljag181
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.